Free Webinar on AI in Cancer Screening 3Dec 11am ET The impact of artificial intelligence (AI) in cancer screening is being felt more and more. From early detection to identifying and prioritizing high-risk individuals, efficient and accurate cancer screening is crucial for improving patient outcomes. AI tools have emerged as a groundbreaking approach to revolutionize cancer detection. In this webinar, moderated by Dr. Sanjay Juneja (VP Clinical AI Applications at Tempus Ai), I am so?pleased to join expert panelists to discuss and evaluate current AI applications in cancer screening, including success stories and ongoing challenges. We will also discuss health disparities when using AI technologies and present strategies for implementing AI-driven screening in low and middle-income countries and underserved communities. Among the key takeaways of this discussion: - Utilizing AI to identify and prioritize high-risk individuals and populations for screening - Health equity: How can AI drive screening in underserved populations including low- and middle-income countries (LMICs) - Improving efficiency and outcomes in cancer screening programs Watch live 3Dec 11am ET or on-demand after. Thanks to everyone for your patience in the reschedule! Click here to register!?https://lnkd.in/e2ZfhJ7d
AI in Precision Oncology
图书期刊出版业
New Rochelle,New York 1,121 位关注者
The only peer-reviewed journal dedicated to the advancement of artificial intelligence in clinical precision oncology
关于我们
AI in Precision Oncology is the only peer-reviewed journal dedicated to the advancement of artificial intelligence applications in clinical and precision oncology. Spearheaded by Editor-in-Chief Douglas Flora, MD and supported by a diverse and accomplished team of international experts, the Journal provides a high-profile forum for cutting-edge research and frontmatter highlighting important research and industry-related advances rapidly developing within the field. The use of AI in oncology has the potential to revolutionize cancer care, from early detection to precision medicine. AI can assist in analyzing complex data, such as genomics, imaging, and electronic health records, to improve cancer diagnosis and treatment planning. Moreover, AI can help predict treatment responses, identify new drug targets, and facilitate clinical trials. The Journal's scope includes all aspects of AI in oncology, from basic research to clinical implementation. AI in Precision Oncology publishes original research articles, reviews, and perspectives on the application of artificial intelligence (AI) in cancer research, diagnosis, and treatment, bringing together researchers, clinicians, and industry experts to share their knowledge and experience in this rapidly evolving field. The Journal helps professionals in the field of oncology understand how artificial intelligence and technology solutions can be applied in an evidence-based, ethical, and thoughtful manner. Overall, the Journal seeks to promote AI's responsible and effective use in oncology, benefiting both healthcare providers and patients.
- 网站
-
https://home.liebertpub.com/publications/ai-in-precision-oncology/679
AI in Precision Oncology的外部链接
- 所属行业
- 图书期刊出版业
- 规模
- 2-10 人
- 总部
- New Rochelle,New York
- 类型
- 私人持股
- 创立
- 2023
地点
-
主要
140 Huguenot St
US,New York,New Rochelle,10801
AI in Precision Oncology员工
-
Mika Newton
CEO @ xCures | Pioneering AI-Powered Precision Medicine
-
Afreen Shariff, MD
Specialist in endocrine disease in cancer | Co-Founder, Citrus Oncology I Closing the global gap in cancer side effect care. Every patient matters.…
-
Blythe Adamson, PhD, MPH
Head of Outcomes Research at Flatiron & Founder of Infectious Economics
-
Aadel Chaudhuri, MD PhD
Physician-Scientist, Liquid Biopsy Researcher, Entrepreneur and Radiation Oncologist
动态
-
Don't miss Dr. Sean Khozin's Roundtable on Cancer at the Second Annual The State of AI in Precision Oncology Summit. ?? Save the Date: Thursday, December 12, 2024 ? Register here: https://bit.ly/3YZ8NWH
The CEO Roundtable on Cancer is pleased to highlight our CEO Dr. Sean Khozin as a featured speaker at the upcoming virtual summit, The State of AI in Precision Oncology 2024. ??? Date: Thursday, December 12, 2024 ? Time: 11:00 AM - 3:15 PM EST ?? Location: Virtual ?? Registration: Free Hosted by AI in Precision Oncology, this summit brings together leading experts in oncology, artificial intelligence, and healthcare innovation to discuss how AI is advancing precision medicine and transforming cancer care. Dr. Khozin will participate in a fireside chat to discuss the state of AI in oncology, its role in personalized treatment approaches, and its potential to improve outcomes for patients worldwide. This summit is an opportunity for healthcare professionals, researchers, investors, and industry leaders to gain insights from some of the foremost voices in AI and oncology. Reserve your spot today: https://lnkd.in/eSctKaU7
-
?? Join The OncDoc himself, Dr. Sanjay Juneja, M.D., at the second Annual State of AI in Precision Oncology Summit 2024! You won't want to miss Dr. Juneja's fireside chat about how AI relates to health care and everything related to oncology from imaging, pathology, and clinical utility as well as administrative. ?? Save the Date: Thursday, December 12, 2024 ??? Register here: https://bit.ly/3YZ8NWH Don’t miss this chance to stay ahead in precision oncology. Let’s shape the future together! #PrecisionOncology #AIInMedicine #HealthcareInnovation #LiebertSummit2024
-
Executive Medical Director | Editor-in-Chief, AI in Precision Oncology | Founder, Tensor Black | American Cancer Society Board OH/KY | ACCC Exec Board | AI Consultant | Board Advisor | Keynote Speaker
?? What better way to end 2024 than by joining AI in Precision Oncology for our second annual “State of AI in Precision Oncology 2024” virtual summit? (and please consider sharing for reach, it is FREE to attend.) Are you curious about where to begin with AI in oncology? Are you unsure which tools are ready for implementation or how to present AI solutions to leadership? Are you looking for ways to enroll more patients in clinical trials, boost efficiency, or reduce clinician burnout? We’ll be tackling these questions and more on December 12. Join us—and >5,000 of your colleagues—for an extraordinary FREE summit packed with cutting-edge insights, expert-led discussions, and practical takeaways that could reshape your practice and accelerate your adoption of AI in precision oncology. Confirmed Speakers: Debra Patt, MD PhD MBA Leroy Hood Caroline Chung Vivek Subbiah, MD Sanjay Juneja, Rajeev Ronanki Sean Khozin I don’t know if there’s a more knowledgeable lineup for these topics anywhere—these speakers are the Navy SEALs of AI in cancer care! Expect dynamic keynotes, in-depth panel discussions, and engaging fireside chats as some of the brightest minds in the field share their insights on how AI is transforming the landscape of precision oncology. Don’t miss this unique opportunity to learn from the field’s top innovators and thought leaders. It’s time to explore the future of oncology—together. ?? Date: Thursday, December 12, 2024 ? Time: 8:00 am PT | 11:00 am ET | 17:00 CET ?? Register Now: bit.ly/3YZ8NWH Sponsorships are still available. Contact Bill Levine?or?Jessica Shook?to learn how your company can participate in the year's most significant AI in Oncology event. #AIInOncology #PrecisionMedicine #CancerCare #HealthcareLeadership #Innovation
-
?? ?? New Date: Harnessing AI to Revolutionize Cancer Screening Webinar We’re thrilled to invite you to an insightful webinar on "Harnessing AI to Revolutionize Cancer Screening", where we'll dive into how AI is transforming early detection, prioritizing high-risk individuals, and addressing health disparities. ?? Date: Monday, December 3, 2024 ? Time: 8:00 am PT | 11:00 am ET | 17:00 CET ?? Register Now: https://bit.ly/3yWiBHZ
-
?? Exciting News! ?? Join us and our EIC Douglas Flora, MD, LSSBB, FACCC at the State of AI in Precision Oncology Summit 2024 to dive into cutting-edge advancements at the intersection of AI and oncology! This is a unique opportunity to learn from experts, explore groundbreaking research, and discuss innovative strategies, the latest tools, and inspiring insights that could transform the future of oncology. ?? Save the Date: Thursday, December 12, 2024 ??? Register here: https://bit.ly/3YZ8NWH Don’t miss this chance to stay ahead in precision oncology. Let’s shape the future together! #PrecisionOncology #AI #HealthcareInnovation #LiebertSummit2024
-
?? Join us for the Second Annual Virtual Summit: The State of AI in Precision Oncology 2024 ?? ?? Register Now: https://bit.ly/3YZ8NWH ?? ??The future of cancer screening is here, and it's powered by Artificial Intelligence! ?? We’re thrilled to invite you to an insightful summit on "The State of AI in Precision Oncology 2024", led by founding Editor-in-Chief Dr. Douglas Flora, MD, LSSBB, FACCC and a distinguished group of pioneering physicians, oncologists, and AI experts. Together, they’ll explore the transformative role of AI in precision oncology through dynamic keynote presentations, thought-provoking panel discussions, and engaging fireside chats. Don’t miss this unique opportunity to gain insights from leaders at the forefront of AI and oncology! ?? Date: Thursday, December 12, 2024 ? Time: 8:00 am PT | 11:00 am ET | 17:00 CET ?? Register Now: https://bit.ly/3YZ8NWH Expert Panelists: Sanjay Juneja, M.D. Debra Patt, MD PhD MBA Lee Hood Caroline Chung Vivek Subbiah, MD Rajeev Ronanki Sean Khozin
-
Executive Medical Director | Editor-in-Chief, AI in Precision Oncology | Founder, Tensor Black | American Cancer Society Board OH/KY | ACCC Exec Board | AI Consultant | Board Advisor | Keynote Speaker
Relentless progress often seems impossible—until it becomes undeniable. When Edward Jenner first introduced the smallpox vaccine, many critics, like physician Benjamin Moseley, scoffed: “Vaccination is a delusion… the frantic ravings of a lunatic.” Yet Jenner’s work not only eradicated smallpox but also revolutionized the way we approach disease prevention. Today, we stand at a similar turning point with AI in oncology. As I discuss in this month’s issue of AI in Precision Oncology, AI may still seem too complex or futuristic to some, but it promises to be just as transformative as any scientific breakthrough. Like the rapidly evolving fields of genomics and immunotherapy, AI is unlocking new pathways—helping us detect cancer earlier, tailor treatments more precisely, and ultimately improve patient outcomes. For those of us in oncology, “Relentless Progress” is not just an ideal—it’s a commitment to staying at the forefront of medicine for the sake of our patients. AI, like these other advances, is here to enhance our ability to provide precise, compassionate care. It’s not replacing us but empowering us to make smarter, faster, and more informed decisions. Yes, there are challenges—concerns about trust, bias, and integration—but just as Jenner’s vaccine eventually silenced its detractors, AI will prove its worth in transforming cancer care. Now is the time to embrace this progress. I encourage you to explore how AI is reshaping oncology by reading my latest piece in AI in Precision Oncology below. AI in Precision Oncology David Penberthy, MD MBA FACCC Sanjay Juneja, M.D. Debra Patt, MD PhD MBA Olalekan Ajayi PharmD MBA FACCC Nikhil Thaker, MD Matt Manning, MD, FASTRO, FACCC Jordan Johnson, MSHA, iMPaCT Isaac Kohane Arturo LoAIza-Bonilla MD Association of Cancer Care Centers American Association for Cancer Research American Cancer Society Sarah Louden Maureen Schnepf Bill Levine Anne Marie Turner Harvey Castro, MD, MBA. Rajeev Ronanki Vivek Subbiah, MD Sean Khozin Oscar P. Tim Showalter
-
?? Last Chance to sign up for our webinar today! ?? "Harnessing AI to Revolutionize Cancer Screening" Date: Sept 23, 2024 Time: 8 am PT | 11 am ET | 5 pm CET Register: https://bit.ly/3yWiBHZ #AIinHealthcare #PrecisionOncology #CancerScreening #MedicalAI #HealthcareInnovation #DigitalHealth #AIinMedicine #CancerResearch?#OncologyTech #HealthTech #AIRevolution #MedicalTechnology?#FutureOfHealthcare #CancerDetection #OncologyInnovation
-
Co-Founder, Massive Bio | Chief of Hematology and Oncology, SLUHN | WebMD Medscape Columnist | AI in Oncology | 40 under 40 in Cancer | OpenAI Forum | HealthTech |
Sharing this article led by Nikhil Thaker, MD where we discuss “Bringing AI to the Clinic for Pancreatic Cancer Care: The Imperative for Seamless Integration into Clinical Workflows” - hope you enjoy it! #AI #pancreaticcancer #cancerresearch AI in Precision Oncology |Capital Health (US) | Massive Bio